MedPath

Flumazenil

Flumazenil Injection, USP

Approved
Approval ID

a72d9fc1-121c-455d-93a9-002378c9968f

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 22, 2020

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

FLUMAZENIL

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-424
Application NumberANDA076955
Product Classification
M
Marketing Category
C73584
G
Generic Name
FLUMAZENIL
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateOctober 20, 2017
FDA Product Classification

INGREDIENTS (8)

FLUMAZENILActive
Quantity: 0.1 mg in 1 mL
Code: 40P7XK9392
Classification: ACTIB
METHYLPARABENInactive
Quantity: 1.8 mg in 1 mL
Code: A2I8C7HI9T
Classification: IACT
PROPYLPARABENInactive
Quantity: 0.2 mg in 1 mL
Code: Z8IX2SC1OH
Classification: IACT
EDETATE DISODIUMInactive
Code: 7FLD91C86K
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.